This week, we will discuss sparsentan again, but this time in FSGS. This is the largest FSGS trial ever. Will endothelin antagonists crack the sclerotic FSGS segment?
SPARE a Thought for SPARSENTAN?
MMF in IgA: Inching into the MAINstream?
NefIgArdians of The Glomerular Galaxy
2021 KDIGO Updates for Glomerular Disease: The Visual Abstract
This update was too big for just one slide! Michael Turk produced two Visual Primers to help you understand the 2021 GN changes at-a-glance.